1. Kaur, R., N. Sharma, V. Bansal, R. Reenu, D.K. Yadav, A. Gupta and D.K. Mahato, 2023. Assessing the protein-ligand interaction and thermally induced quality changes in tomato-based pineapple beverage. Beverages, Vol. 9. 10.3390/beverages9010012.
   CrossRef  |  Direct Link  |  
2. Faruqui, T., M.S. Khan, Y. Akhter, S. Khan, Z. Rafi, M. Saeed, I. Han, Eun-Ha Choi and D.K. Yadav, 2023. RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review Int. J. Mol. Sci. Vol. 24. 10.3390/ijms24010266.
   CrossRef  |  Direct Link  |  
3. Yousuf, M., A. Shamsi, F. Anjum, A. Shafie, A. Islam., 2022. Effect of pH on the structure and function of cyclin-dependent kinase 6. PLoS ONE, Vol 17, 10.1371/journal.pone.0263693.
   CrossRef  |  Direct Link  |  
4. Yousuf, M., A. Ali, P. Khan, F. Anjum and A.M. Elasbaliet al., 2022. Insights into the Antibacterial Activity of Prolactin-Inducible Protein against the Standard and Environmental MDR Bacterial Strains Microorganisms, Vol. 10. 10.3390/microorganisms10030597.
   CrossRef  |  Direct Link  |  
5. Yang, C., A. Alam, F.A. Alhumaydhi, M.S. Khan and S.A. Alsagabyet al., 2022. Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics. Molecules,Vol. 27. 10.3390/molecules27103060.
   CrossRef  |  Direct Link  |  
6. Yadav, D.K., 2022. Recent advances in small molecule medicinal chemistry to treat human
   diseases: part v. Curr. Top. Med. Chem., 22: 834-834.
   CrossRef  |  Direct Link  |  
7. Tasleem, M., A. Shoaib, A. Al-Shammary, A. Abdelgadir and Z. Alsamaret al., 2022. Computational analysis of PTP-1B site-directed mutations and their structural binding to potential inhibitors. Cell Mol. Biol. (Noisy-le-grand), 68: 75-84.
   CrossRef  |  Direct Link  |  
8. Singh, D.D.,A. Sharma, Hae-Jeung Lee and D.K. Yadav, 2022. SARS-CoV-2: Recent variants and clinical efficacy of antibody-based therapy. Front. Cell. Infect. Microbiol. Vol. 12. 10.3389/fcimb.2022.839170.
   CrossRef  |  Direct Link  |  
9. Singh, D.D., Hae-Jeung Lee and D.K. Yadav, 2022. Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer. Front. Pharmacol. Vol.13. 10.3389/fphar.2022.1089066.
   CrossRef  |  Direct Link  |  
10. Singh, D.D., A.A. Shati, M.Y. Alfaifi, S.E.I. Elbehairi, I. Han, Eun-Ha Choi and D.K. Yadav, 2022. Development of dementia in type 2 diabetes patients: Mechanisms of insulin resistance and antidiabetic drug development. cells , Vol. 11. 10.3390/cells11233767.
    CrossRef  |  Direct Link  |  
11. Singh, D.D., A. Parveen and D.K. Yadav, 2022. Corrigendum: Sars-cov-2: Emergence of new variants and effectiveness of vaccines. Front. Cell. Infect. Microbiol. Vol. 12. 10.3389/fcimb.2022.885482.
    CrossRef  |  Direct Link  |  
12. Shyamlal, B.R.K., M. Mathur, D.K. Yadav, I.V. Mashevskaya, M. El-Shazly, N. Saleh and S. Chaudhary, 2022. Discovery of natural product inspired 3-phenyl-1h-isochromen-1-ones as highly potent antioxidant and antiplatelet agents: design, synthesis, biological evaluation, sar andin silicostudies. Curr. Pharm. Des., 28: 829-840.
    CrossRef  |  Direct Link  |  
13. Shamsi, A., M. Shahwan, M.S. Khan, F.A. Alhumaydhi, S.A. Alsagaby, W.A. Abdulmonem, B. Abdullaev and D.K. Yadav, 2022. Mechanistic insight into binding of huperzine a with human serum albumin: Computational and spectroscopic approaches. Molecules,Vol. 27. 10.3390/molecules27030797.
    CrossRef  |  Direct Link  |  
14. Shamsi, A., D. DasGupta, F.A. Alhumaydhi, M.S. Khan, S.A. Alsagabyet al., 2022. Inhibition of MARK4 by serotonin as an attractive therapeutic approach to combat Alzheimers disease and neuroinflammation. RSC Med. Chem., 13: 737-745.
    CrossRef  |  Direct Link  |  
15. Saeed, M., M. Tasleem, A. Shoaib, N.M. Alabdallah and Md. J. Alamet al., 2022. Investigation of antidiabetic properties of shikonin by targeting aldose reductase enzyme: In silico and in vitro studies. Biomed. Pharmacother. Vol. 150. 10.1016/j.biopha.2022.112985.
    CrossRef  |  Direct Link  |  
16. Patel, M., K. Patel, L.A. Al-Keridis, N. Alshammari, R. Badraoui., 2022. Cadmium-tolerant plant growth-promoting bacteria curtobacterium oceanosedimentum improves growth attributes and strengthens antioxidant system in chili (capsicum frutescens). Sustainability, Vol. 14. 10.3390/su14074335.
    CrossRef  |  Direct Link  |  
17. Pandey, P., R. Sahoo, K. Singh, S. Pati and J. Mathewet al., 2022. Drug Resistance Reversal Potential of Nanoparticles/Nanocomposites via Antibiotic’s Potentiation in Multi Drug Resistant P. aeruginosa Nanomaterials, Vol. 12. 10.3390/nano12010117.
    CrossRef  |  Direct Link  |  
18. Noor, S., T. Mohammad, M.A. Rub, A. Raza and N. Azum., 2022. Biomedical features and therapeutic potential of rosmarinic acid. Arch. Pharm. Res., 45: 205-228.
    CrossRef  |  Direct Link  |  
19. Ng, J.P.L., M.K. Tiwari, A.A. Nasim, R.L. Zhang and Y. Qu,et al., 2022. Biological evaluation in resistant cancer cells and study of mechanism of action of arylvinyl-1,2,4-trioxanes. Pharmaceuticals, Vol. 15. 10.3390/ph15030360.
    CrossRef  |  Direct Link  |  
20. Md.I., D. Anjum, T. Mohammad, M. Alam, M.S. Khan, M. Shahwan, A. Shamsi and D.K. Yadav, 2022. Integrated virtual screening and MD simulation study to discover potential inhibitors of Lyn-kinase: targeting cancer therapy J. Biomol. Struct. Dyn., 10.1080/07391102.2022.2154849.
    CrossRef  |  Direct Link  |  
21. M. Alam, G.M. Hasan, Md.M. Ansari, R. Sharma, D.K. Yadav and Md.I. Hassan, 2022. Therapeutic implications and clinical manifestations of thymoquinone. Phytochemistry, Vol. 200. 10.1016/j.phytochem.2022.113213.
    CrossRef  |  Direct Link  |  
22. Khan, M.S., M. Shahwan, A. Shamsi, F.A. Alhumaydhi, S.A. Alsagabyet al., 2022. Elucidating the interactions of fluoxetine with human transferrin employing spectroscopic, calorimetric, and in silico approaches: implications of a potent alzheimer’s drug. ACS. Omega, 7: 9015-9023.
    CrossRef  |  Direct Link  |  
23. Kaur, H., K. Kaur, A. Singh, N. Bedi and B. Singhet al., 2022. Frankincense oil-loaded nanoemulsion formulation of paclitaxel and erucin: A synergistic combination for ameliorating drug resistance in breast cancer: In vitro and in vivo study Front. Pharmacol., 10.3389/fphar.2022.1020602.
    CrossRef  |  Direct Link  |  
24. Han, I., S. Mumtaz, S. Ashokkumar, D.K. Yadav and E.H. Choi, 2022. Review of developments in combating covid-19 by vaccines, inhibitors, radiations, and nonthermal plasma. Curr. Issues Mol. Biol., 44: 5666-5690.
    CrossRef  |  Direct Link  |  
25. Choudhury, A., T. Mohammad, F. Anjum, A. Shafie and I.K. Singhet al., 2022. Comparative analysis of web-based programs for single amino acid substitutions in proteins.. PLoS ONE, Vol 17, 10.1371/journal.pone.0267084.
    CrossRef  |  Direct Link  |  
26. Bal, S., A.B. Sharangi, T.K. Upadhyay, F. Khan and P. Pandey et al., 2022. Biomedical and antioxidant potentialities in chilli: Perspectives and way forward. Molecules, Vol. 27. 10.3390/molecules27196380.
    CrossRef  |  Direct Link  |  
27. Badraoui, R., M. Saoudi, W.S. Hamadou, S. Elkahoui and A.J. Siddiquiet al., 2022. Antiviral Effects of Artemisinin and Its Derivatives against SARS-CoV-2 Main Protease: Computational Evidences and Interactions with ACE2 Allelic Variants Pharmaceuticals, Vol. 15. 10.3390/ph15020129.
    CrossRef  |  Direct Link  |  
28. Anjum, F., T. Mohammad, P. Asrani, A. Shafie and S. Singhet al., 2022. Identification of intrinsically disorder regions in non-structural proteins of SARS-CoV-2: New insights into drug and vaccine resistance. Mol. Cell. Biochem., 477: 1607-1619.
    CrossRef  |  Direct Link  |  
29. Anjum, F., Md N. Sulaimani, A. Shafie, T. Mohammad and G. Md. Ashrafet al., 2022. Bioactive phytoconstituents as potent inhibitors of casein kinase-2: dual implications in cancer and COVID-19 therapeutics. RSC Adv., 12: 7872-7882.
    CrossRef  |  Direct Link  |  
30. Alshehri, A., A. Ahmad, R.K. Tiwari, I. Ahmad and A.G. Alkhathami et al., 2022. In vitro evaluation of antioxidant, anticancer, and anti-inflammatory activities of ethanolic leaf extract of Adenium obesum. Front. Pharmacol., Vol. 13. 10.3389/fphar.2022.847534.
    CrossRef  |  Direct Link  |  
31. Almeleebia, T.M., S. Ahamad, I. Ahmad, A. Alshehri, A.G. Alkhathamiet al., 2022. Identification of parp12 inhibitors by virtual screening and molecular dynamics simulations. Front. Pharmacol. , 10.3389/fphar.2022.847499.
    CrossRef  |  Direct Link  |  
32. Alam, M., S. Ali, G.Md. Ashraf, A.L. Bilgrami, D.K. Yadav and Md.I. Hassan, 2022. Epigallocatechin 3-gallate: From green tea to cancer therapeutics. Food Chem., Vol. 379. 10.1016/j.foodchem.2022.132135.
    CrossRef  |  Direct Link  |  
33. Adnan, M., D.S. Jairajpuri, M. Chaddha, M.S. Khan, D.K. Yadavet al., 2022. Discovering Tuberosin and Villosol as Potent and Selective Inhibitors of AKT1 for Therapeutic Targeting of Oral Squamous Cell Carcinoma. J. Pers. Med. Vol. 12. 10.3390/jpm12071083.
    CrossRef  |  Direct Link  |  
34. Yadav, D.K., D.D. Singh, I. Han, Y. Kumar and Eun-Ha Choi, 2021. Current potential therapeutic approaches against sars-cov-2: A review. Biomedicines, Vol. 9. 10.3390/biomedicines9111620.
    CrossRef  |  Direct Link  |  
35. Yadav, D.K., 2021. Recent advances on small molecule medicinal chemistry to treat human diseases-part III. Curr. Top. Med. Chem., 21: 1517-1518.
    CrossRef  |  Direct Link  |  
36. Waseem, R., S. Anwar, S. Khan, A. Shamsi and Md.I. Hassanet al., 2021. MAP/microtubule affinity regulating kinase 4 inhibitory potential of irisin: A new therapeutic strategy to combat cancer and alzheimer’s disease. Int. J. Mol. Sci. Vol. 22. 10.3390/ijms222010986.
    CrossRef  |  Direct Link  |  
37. Singh, D.D., A. Parveen and D.K. Yadav, 2021. SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines Front. Cell. Infect. Microbiol. Vol. 11. 10.3389/fcimb.2021.777212.
    CrossRef  |  Direct Link  |  
38. Singh, D.D., A. Parveen and D.K. Yadav, 2021. Role of parp in tnbc: mechanism of inhibition, clinical applications, and resistance. Biomedicines, Vol. 9. 10.3390/biomedicines9111512.
    CrossRef  |  Direct Link  |  
39. Singh, D.D. and D.K. Yadav, 2021. TNBC: Potential targeting of multiple receptors for a therapeutic breakthrough, nanomedicine, and immunotherapy. Biomedicines, Vol. 9. 10.3390/biomedicines9080876.
    CrossRef  |  Direct Link  |  
40. Shafie, A., S. Khan, S. Batra, F. Anjum and T. Mohammadet al., 2021. Investigating single amino acid substitutions in PIM1 kinase: A structural genomics approach. PLoS ONE, Vol 16, 10.1371/journal.pone.0258929.
    CrossRef  |  Direct Link  |  
41. Shafie, A., S. Khan, Zehra, T. Mohammad, F. Anjumet al., 2021. Identification of phytoconstituents as potent inhibitors of casein kinase-1 alpha using virtual screening and molecular dynamics simulations. Pharmaceutics, Vol. 13. 10.3390/pharmaceutics13122157.
    CrossRef  |  Direct Link  |  
42. Rana, R., V. Rathi, K. Chauhan, K. Jain, S.S. Chhabraet al., 2021. Exploring the role of epidermal growth factor receptor variant III in meningeal tumors. PLoS ONE, Vol 16, 10.1371/journal.pone.0255133.
    CrossRef  |  Direct Link  |  
43. Noor, S., T. Mohammad, G.M. Ashraf, J. Farhat and A.L. Bilgramiet al., 2021. Mechanistic insights into the role of serum-glucocorticoid kinase 1 in diabetic nephropathy: A systematic review. Int. J. Biol. Macromol., 193: 562-573.
    CrossRef  |  Direct Link  |  
44. Naqvi, A.A.T., F. Anjum, A. Shafie, S. Badar, A.M. Elasbali, D.K. Yadav and Md.I. Hassan, 2021. Investigating host-virus interaction mechanism and phylogenetic analysis of viral proteins involved in the pathogenesis. PLoS ONE, Vol 16, 10.1371/journal.pone.0261497.
    CrossRef  |  Direct Link  |  
45. Mohammad, T., A. Choudhury, I. Habib, P. Asrani and Y. Mathuret al., 2021. Genomic variations in the structural proteins of sars-cov-2 and their deleterious impact on pathogenesis: a comparative genomics approach. Front. Cell. Infect. Microbiol. Vol. 11. 10.3389/fcimb.2021.765039.
    CrossRef  |  Direct Link  |  
46. Dwivedi, G.R., R. Rai, R. Pratap, K. Singh and S. Patiet al., 2021. Drug resistance reversal potential of multifunctional thieno[3,2-c]pyran via potentiation of antibiotics in MDR P. aeruginosa. Biomed. Pharmacother. Vol. 142. 10.1016/j.biopha.2021.112084.
    CrossRef  |  Direct Link  |  
47. D. Kumar, D.K. Yadav and Md.I. Hassan, 2021. Topical Insights Into the post-approval controversies of aducanumab. Front. Pharmacol. Vol. 12. 10.3389/fphar.2021.787303.
    CrossRef  |  Direct Link  |  
48. Alam, M., S. Ali, T. Mohammad, G.M. Hasan, D.K. Yadav and Md.I. Hassan, 2021. B Cell Lymphoma 2: A Potential therapeutic target for cancer therapy. Int. J. Mol. Sci. Vol. 22. 10.3390/ijms221910442.
    CrossRef  |  Direct Link  |  
49. Alam, M., S. Ali, S. Ahmed, A.M. Elasbali, M. Adnanet al., 2021. Therapeutic potential of ursolic acid in cancer and diabetic neuropathy diseases. Int. J. Mol. Sci. Vol. 22. 10.3390/ijms222212162.
    CrossRef  |  Direct Link  |